Domestic MF AUM declines by 4 per cent.
Domestic MF AUM declines by 4 per cent.

Domestic MF AUM declines by 4 per cent.

DSIJ Intelligence Article rating: 5.0

The latest data by industry body, Association of Mutual Funds in India (AMFI) shows that asset under management (AUM) of the domestic mutual fund has declined by 3.8% month on month basis.

Polycab India opens its second Experience Centre
Polycab India opens its second Experience Centre

Polycab India opens its second Experience Centre

DSIJ Intelligence Article rating: 3.5

Polycab India Limited on Wednesday announced that the company has inaugurated Polycab Experience Centre at Shop No. 1, Sakharam Apartment, old Tapkir Galli, Pune.

Religare Enterprises to conduct postal ballot for disinvestment
Religare Enterprises to conduct postal ballot for disinvestment

Religare Enterprises to conduct postal ballot for disinvestment

DSIJ Intelligence Article rating: 5.0

Last week, Religare Enterprises announced that the company will conduct postal ballot to obtain approval of the shareholders of the company by the way of special resolution on disinvestment of entire investment of the company in material subsidiaries and Religare Housing Development Finance Corporation Limited and Sales, disposal and leasing of assets exceeding 20 per cent of assets of Religare Finvest Limited.

Understanding the game of needs and wants
Understanding the game of needs and wants

Understanding the game of needs and wants

DSIJ Intelligence Article rating: 5.0

Usually, people use the words “need” and “want” interchangeably. However, they are way different from each other. Read on to find out more.

Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets
Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets

Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets

Apurva Joshi Article rating: 5.0

Zydus Cadila has received the final approval from the United States Federation of Drug Authority (USFDA) to market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

DSIJ Intelligence Article rating: 5.0

The markets on October 09, 2019 opened gap up. BSE Sensex is trading at 37,991.57, up by 459.59 points and the Nifty is closed at 11,256.80, up by 130.40 points.

Lupin gets GMP certificate for Mandideep API facility
Lupin gets GMP certificate for Mandideep API facility

Lupin gets GMP certificate for Mandideep API facility

Apurva Joshi Article rating: 4.5

Lupin Limited has informed the bourses that it has received GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II).

BHEL gains on new order win
BHEL gains on new order win

BHEL gains on new order win

Nidhi Jani Article rating: 4.0

The public sector company informed the exchanges that it has won orders for the Turbine Generator and associated packages for the greenfield 2x660 MW Khurja Super Thermal Power Project situated at Bulandshahr district of Uttar Pradesh.

Raymond jumps 9 per cent on property deal
Raymond jumps 9 per cent on property deal

Raymond jumps 9 per cent on property deal

Nidhi Jani Article rating: 4.3

Raymond has forayed into real estate business in FY19. Around 20 acres of land has been approved for residential development and, at present, 14 acres are being developed. In this residential project, Raymond will develop overall 3,000 residential units across 10 towers.

RSS
First31413142314331443146314831493150Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR